Cellestia Biotech

Business Services · 11-50 Employees

View Company Info for Free

Overview

Phone Number

+41 616332980

Revenue

$5.3 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Cellestia Biotech

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-drug resistant cancers. Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland.Explore more
Cellestia Biotech's Social MediaPopular SearchesCellestia Biotech AGCellestia BiotechCellestiaCellestia Biotech SASIC Code 87,873NAICS Code 54,541Show more

Is Cellestia Biotech your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Cellestia Biotech is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Cellestia Biotech is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Cellestia Biotech.

Cellestia Biotech financials insights

Gather financial insights about Cellestia Biotech, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2017

Angel/Seed

$5.2M

2018

Series A

$21.3M

2019

Series B

$20.4M

See All Cellestia Biotech's Financials Insights

Cellestia Biotech Tech Stack

A closer look at the technologies used by Cellestia Biotech

Most Recent Scoops

Event
Events
Left Company
Executive Move
Event
will be attending the 2022 BIO International Convention conference as an exhibitor. The event will occur from June 13 to June 16, 2022.
Funding
Funding
See more scoops

Top Business Services Companies

Frequently Asked Questions Regarding Cellestia Biotech

What is Cellestia Biotech's official website?
Cellestia Biotech's official website is www.cellestia.com
What is Cellestia Biotech's Revenue?
Cellestia Biotech's revenue is $5.3 Million
What is Cellestia Biotech's SIC code?
Cellestia Biotech's SIC: 87,873
What is Cellestia Biotech's NAICS code?
Cellestia Biotech's NAICS: 54,541
How many employees does Cellestia Biotech have?
Cellestia Biotech has 11-50 employees
What industry does Cellestia Biotech belong to?
Cellestia Biotech is in the industry of: Business Services, Research & Development
What technology does Cellestia Biotech use?
Some of the popular technologies that Cellestia Biotech uses are: WordPress.org, PHP, AddToAny, Google Font API
How do I contact Cellestia Biotech?
Cellestia Biotech contact info: Phone number: +41 616332980 Website: www.cellestia.com
What does Cellestia Biotech do?

Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression in multiple disease areas by selective inhibition of transcription factors in the cell nucleus. The lead compound CB-103 has advanced to Phase 2 successfully treating patients with multi-drug resistant cancers.... Further, Cellestia is advancing a rich R&D pipeline of novel transcription factor inhibitors, in oncology, auto-immune and inflammatory disorders, having achieved animal in-vivo proof of concept for several new targets. Cellestia was founded in 2014 as a spin-off from EPFL, Lausanne, Switzerland and is headquartered in Basel, Switzerland.Read More

What are Cellestia Biotech social media links?
Cellestia Biotech Linkedin page Cellestia Biotech Twitter page
Who invested in Cellestia Biotech?
Cellestia Biotech has 6 investors including Partners Investment, PPF Group, FC Capital and PPF Group.
Is Cellestia Biotech a public company?
Cellestia Biotech is private company therefore does not currently have an official ticker symbol
See more information about Cellestia Biotech

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.